2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss]
lebrikizumab-lbkz
RxCUI: 2693791
What the CMS Formulary Data Shows for 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss]
Per the CMS 2026 Part D formulary file, 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] (RxNorm concept RXCUI 2693791, generic name lebrikizumab-lbkz) appears on 15 distinct formulary files spanning 927 Medicare Part D plan offerings - 18.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] depends on utilization management as much as tier placement: 93.3% of covering formularies require prior authorization. 0% require step therapy. 46.7% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] today.
Coverage Details
- Formularies covering
- 15
- Plans covering
- 927
- Coverage rate
- 18.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 93.3% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 46.7% of formularies
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss]
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T5 | Yes | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T5 | Yes | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss]
98 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | FALLON COMMUNITY HEALTH PLAN | T1 | Yes | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | Yes | $0 | MA |
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | UNITEDHEALTHCARE OF WISCONSIN, INC. | T5 | Yes | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | UNITEDHEALTHCARE OF WISCONSIN, INC. | T5 | Yes | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | UNITEDHEALTHCARE OF WISCONSIN, INC. | T5 | Yes | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | UNITEDHEALTHCARE OF WISCONSIN, INC. | T5 | Yes | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | UNITEDHEALTHCARE OF WISCONSIN, INC. | T5 | Yes | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | UNITEDHEALTHCARE OF WISCONSIN, INC. | T5 | Yes | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | UNITEDHEALTHCARE PLAN OF THE RIVER VALLEY, INC. | T5 | Yes | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | UNITEDHEALTHCARE PLAN OF THE RIVER VALLEY, INC. | T5 | Yes | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | UNITEDHEALTHCARE PLAN OF THE RIVER VALLEY, INC. | T5 | Yes | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | UNITEDHEALTHCARE INSURANCE COMPANY | T5 | Yes | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | UNITEDHEALTHCARE INSURANCE COMPANY | T5 | Yes | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | UNITEDHEALTHCARE INSURANCE COMPANY | T5 | Yes | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | UNITEDHEALTHCARE INSURANCE COMPANY | T5 | Yes | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | ARIZONA PHYSICIANS IPA, INC. | T5 | Yes | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | ARIZONA PHYSICIANS IPA, INC. | T5 | Yes | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | CARE IMPROVEMENT PLUS SOUTH CENTRAL INSURANCE CO. | T5 | Yes | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | UNITEDHEALTHCARE OF THE MIDLANDS, INC. | T5 | Yes | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-0012 (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-004P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-005P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-006P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| UHC Sharp Medicare Advantage ValueRx CA-12P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-021P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-022P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-023P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage from UHC CA-026P (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage Giveback from UHC CA-19 (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage Giveback from UHC CA-20 (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage Giveback from UHC CA-21 (HMO-POS) | UHC OF CALIFORNIA | T5 | Yes | $0 | CA |
| AARP Medicare Advantage Essentials from UHC CO-2 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | CO |
| AARP Medicare Advantage Essentials from UHC AZ-1 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | AZ |
| AARP Medicare Advantage Essentials from UHC AZ-2 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | AZ |
| AARP Medicare Advantage from UHC AZ-002P (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | AZ |
| AARP Medicare Advantage from UHC NV-0001 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | NV |
| AARP Medicare Advantage from UHC NV-0002 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | NV |
| UHC Medicare Advantage NV-001P (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | NV |
| AARP Medicare Advantage Essentials from UHC CO-4 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | CO |
| AARP Medicare Advantage Essentials ValueRx NV-5 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | NV |
| AARP Medicare Advantage from UHC NV-0006 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | NV |
| AARP Medicare Advantage Extras from UHC AZ-4 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | AZ |
| AARP Medicare Advantage Extras from UHC AZ-5 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | AZ |
| AARP Medicare Advantage Extras from UHC CO-5 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | CO |
| AARP Medicare Advantage Essentials from UHC TX-21 (HMO-POS) | UnitedHealthcare Benefits of Texas, Inc. | T5 | Yes | $0 | TX |
Frequently Asked Questions
Is 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] covered by Medicare Part D?
Yes, 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] is covered by 927 Medicare Part D plans (18.3% of all Part D formularies).
What tier is 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] on Medicare Part D plans?
2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] require prior authorization?
93.3% of Part D formularies require prior authorization for 2 ML lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss]. Step therapy: 0%. Quantity limits: 46.7%.
Read our methodology - how this data is sourced, computed, and verified.